The FINANCIAL — Roche announced on October 5 that its new, dedicated high-throughput HbA1c testing solution, the cobas c 513 analyser, is now available for countries accepting the CE mark. “The ...
The FDA announced that it has granted marketing approval for Roche Laboratories‘ COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by healthcare ...
Roche’s cobas c 513 analyzer and HbA1c Gen. 3 assay has received clearance from the FDA, according to a company press release. The cobas c 513 analyzer is laboratory device for measuring HbA1c that ...
Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health ...
FDA clears HbA1c test for diabetes diagnosis Previously, the FDA has only allowed manufacturers to market HbA1c tests as tools for monitoring blood glucose, not diagnosis. Clinicians can officially ...
PLEASANTON, Calif., Feb. 13, 2018 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received FDA clearance for the cobas® Factor II and Factor V Test for use on the cobas® ...
Hosted on MSN
HbA1c Test: HbA1c test for accurate information about diabetes, know who should get this test done
The way the risk of many types of serious diseases is increasing all over the world is definitely a matter of concern. Health experts say that it is important for everyone to know their risks and take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback